Showing results (201-210 of 213) with videos related to
Sort By:
Pageof 22
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2014
Hepatobiliary cancers, version 2.2014Al B Benson, Michael I D'Angelica, Thomas A Abrams, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 30, 2020
Insulin-Like Growth Factor-1 Receptor Expression and Disease Recurrence and Survival in Patients with Resected Pancreatic Ductal AdenocarcinomaChunxia Du, Annacarolina da Silva, Vicente Morales-Oyarvide, et al.Cell|April 19, 2020
Endocrine-Exocrine Signaling Drives Obesity-Associated Pancreatic Ductal AdenocarcinomaKatherine Minjee Chung, Jaffarguriqbal Singh, Lauren Lawres, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2020
Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic CancerSara A Väyrynen, Jinming Zhang, Chen Yuan, et al.Journal of the National Comprehensive Cancer Network : JNCCN|April 9, 2019
Guidelines Insights: Hepatobiliary Cancers, Version 2.2019Al B Benson, Michael I D'Angelica, Daniel E Abbott, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2022
Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic CancerAndressa Dias Costa, Sara A Väyrynen, Akhil Chawla, et al.British Journal of Cancer|October 6, 2017
Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survivalVicente Morales-Oyarvide, Douglas A Rubinson, Richard F Dunne, et al.Journal of the National Comprehensive Cancer Network : JNCCN|May 24, 2021
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyAl B Benson, Michael I D'Angelica, Daniel E Abbott, et al.JCI Insight|September 17, 2024
SLC4A11 mediates ammonia import and promotes cancer stemness in hepatocellular carcinomaAmeer L Elaimy, Marwa O El-Derany, Jadyn James, et al.Practical Radiation Oncology|January 20, 2024
Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert ConsensusTed K Yanagihara, Joel E Tepper, Andrew M Moon, et al.Pageof 22